Personnel Moves Archives - Page 42 of 42

B. Braun’s top North American executive to retire

Caroll H. Neubauer will retire at the end of August as the head of B. Braun’s North America operations.

B. Braun announced today that Caroll H. Neubauer will retire at the end of August after 24 years leading the Melsungen, Germany–based medical and drug delivery device giant’s North America operations.

Jean-Claude Dubacher, a former Johnson & Johnson and Abbott executive who already took over Neubauer’s role as CEO of B. Braun Medical at the start of the year, has now also assumed Neubauer’s position as chair and CEO of B. Braun of America, effective June 1. Neubauer will stay on until Aug. 31 as executive director of B. Braun of America.

Get the full story on our sister site MassDevice.

B. Braun’s top North American executive to retire

Caroll H. Neubauer will retire at the end of August as the head of B. Braun’s North America operations.

B. Braun announced today that Caroll H. Neubauer will retire at the end of August after 24 years leading the Melsungen, Germany–based medical and drug delivery device giant’s North America operations.

Jean-Claude Dubacher, a former Johnson & Johnson and Abbott executive who already took over Neubauer’s role as CEO of B. Braun Medical at the start of the year, has now also assumed Neubauer’s position as chair and CEO of B. Braun of America, effective June 1. Neubauer will stay on until Aug. 31 as executive director of B. Braun of America.

Based in Bethlehem, Pa., B. Braun of America includes B. Braun Medical (also in Bethlehem), B. Braun Interventional Systems, Aesculap and Central Admixture Pharmacy Services (CAPS). Under Neubauer’s leadership, the North America ope…

Nevro appoints MacLeod as CFO

Nevro (NYSE:NVRO) announced today that it appointed Roderick MacLeod as its new chief financial officer, effective June 15.

MacLeod will succeed current CFO Andrew Galligan, who is set to retire, but will remain on with the company during a transition period as MacLeod takes over. Galligan spent 10 years at Nevro, according to a news release.

“I’m very pleased to join Nevro and I view this as an exciting opportunity to continue to build a great company while helping patients who suffer from chronic pain,” MacLeod said in the release. “I look forward to working closely with Keith and the rest of the Nevro team to execute on the Company’s growth strategy.”

Prior to taking on this new role, the 25-year veteran of financial and executive leadership roles in healthcare and technology spent 16 years at Stryker (NYSE:SYK). He served as VP of finance at Stryker Endoscopy and, before that, controller for the same division. Mac…

3M appoints Patolawala as new CFO

3M (NYSE:MMM) announced today that it appointed Monish Patolawala as its new senior VP and chief financial officer, effective July 1.

Patolawala is set to succeed Nick Gangestad, who announced that he is retiring, but will stay on through July 31 in an effort to ensure an orderly transition. Gangestad spent 35 years with 3M, according to a news release.

Currently the CFO at General Electric Healthcare (NYSE:GE), Patolawala has been with GE since 1994, also recently serving as VP of operational transformation at the company.

“I am pleased to welcome Monish to our leadership team,” 3M chairman & CEO Mike Roman said in the news release. “His deep and extensive experience in leading the financial operations of industrial and healthcare businesses – as well as driving operational changes – will make an immediate impact as we manage through the current economic challenges and continue to position 3M for the future. I am confident Monish will provide strong…

Arterys raises $28m Series C

Arterys, a medical imaging software developer for clinical AI products, announced today that it raised $28 million in a Series C financing round.

Benslie Investment Group and Temasek Holdings led the funding, while Fosun, Revelation Partners, Emergent Medical Partners and Varian Medical Systems participated as well.

San Francisco-based Arterys said in a news release that it intends to use the funds to broaden its ecosystem, which includes a broad set of partners on its new marketplace that utilizes its cloud platform.

Much focus will gear toward accelerating partners’ efforts to bring new, clinical-grade AI applications to providers by extending the Arterys technology platform to application partners so they can integrate AI into their workflows, the company said.

Additionally, Arterys appointed co-founder John Axerio-Cilies as its acting CEO. According to a previous press release, Axerio-Cilies previously held the role of chief tech…

Iradimed CEO resigns; replacement named

Iradimed (NSDQ:IRMD) announced today that it appointed former president and CEO Roger Susi to resume the roles 10 months after he stepped down.

On July 29, 2019, the Winter Springs, Fla.-based MRI-compatible medical device developer announced that Susi would continue as the company’s chairman and chief technology officer, while Leslie McDonnell would assume the roles of president and CEO.

However, McDonnell separated from the company effective yesterday, according to a news release, leading to the reappointment of Susi, who had led the company for 27 years from its founding before stepping down last year.

“I look forward to resuming as the company’s president and CEO and would like to thank Ms. McDonnell for her contributions during her tenure,” Susi said in the release. “I remain optimistic about our future and am excited to lead Iradimed through its next stages of growth.” In McDonnel’s last quarter as president and CEO, Iradimed increa…

Siren raises $11.8m Series B

Siren, a developer of smart textiles with remote patient monitoring applications, announced today that it raised $11.8 million in a Series B financing.

The San Francisco-based medical device company had its funding round led by Anathem Ventures, with participation from existing investors DCM, Khosla Ventures, 500 Startups and Peter Thiel’s Founders Fund. Additionally, DCM partner Jason Krikorian will join Siren’s board and Anathem managing partner Crystal McKellar will join Siren as an advisor.

Siren’s latest round of funding adds nearly $12 million to the $22 million it has already raised across three funding rounds since its founding in 2015, according to a news release. The company noted in the release that the finances it has secured is helping it to position itself for commercial expansion.

The company’s portfolio includes a temperature-monitoring sock capable of connecting wirelessly to a software application, allowing podi…

Medtronic appoints new VP & CMO for coronary, renal denervation & structural heart

Medtronic (NYSE:MDT) announced that it appointed Dr. Jeffrey Popma as its new VP and chief medical officer for coronary, renal denervation and structural heart business.

Popma, a professor of medicine at Harvard Medical School and director of interventional cardiology at Beth Israel Deaconess Medical Center in Boston, is slated to provide medical leadership across those businesses, serve as a strategic advisor for cardiovascular device innovation and help to develop a clinical research portfolio, according to a news release.

He is set to assume the role on June 22 and report to Nina Goodheart, president of the coronary & structural heart division as part of the cardiac and vascular group.

“I am honored to be joining Medtronic to help deliver on its enduring Mission of patient-focused medical device innovation,” Popma said in the release. “I look forward to collaborating with the talented cardiovascular and structural heart teams at Medtro…